Smruthi Organics Limited is engaged in the manufacture and sale of bulk drugs and drug intermediates (active pharmaceutical ingredient (API) products). The Company's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The Company has approximately two manufacturing facilities in Solapur, Maharashtra, India, with a combined reactor capacity of over 320 kiloliters. The Company manufactures API from kilo to metric ton scale. The Company serves pharmaceutical companies in India and across the globe.